Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avidity Biosciences (RNA) Receivables: 2022-2023

Historic Receivables for Avidity Biosciences (RNA) over the last 2 years, with Dec 2023 value amounting to $1.1 million.

  • Avidity Biosciences' Receivables was N/A to $1.6 million in Q1 2024 from the same period last year, while for Mar 2024 it was $6.2 million, marking a year-over-year change of. This contributed to the annual value of $1.1 million for FY2023, which is 53.26% down from last year.
  • Per Avidity Biosciences' latest filing, its Receivables stood at $1.1 million for FY2023, which was down 53.26% from $2.4 million recorded in FY2022.
  • Over the past 5 years, Avidity Biosciences' Receivables peaked at $2.4 million during FY2022, and registered a low of $1.1 million during FY2023.
  • For the 2-year period, Avidity Biosciences' Receivables averaged around $1.7 million, with its median value being $1.7 million (2022).
  • Data for Avidity Biosciences' Receivables shows a maximum YoY tumbled of 53.26% (in 2023) over the last 5 years.
  • Avidity Biosciences' Receivables (Yearly) stood at $2.4 million in 2022, then slumped by 53.26% to $1.1 million in 2023.